Literature DB >> 19770510

Resolving lung injury: a new role for Tregs in controlling the innate immune response.

Anthony Pietropaoli1, Steve N Georas.   

Abstract

Inflammation-associated lung injury is a major cause of morbidity and mortality for patients in intensive care units. Although the cellular and molecular events that initiate lung inflammation are now well understood, the mechanisms that promote its resolution remain poorly defined. In this issue of the JCI, D'Alessio et al. show in a mouse model that recovery from acute lung injury is not simply a passive process, but involves Tregs in an active resolution program (see the related article beginning on page 2898).

Entities:  

Mesh:

Year:  2009        PMID: 19770510      PMCID: PMC2752113          DOI: 10.1172/JCI40880

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  The acute respiratory distress syndrome.

Authors:  L B Ware; M A Matthay
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

Authors:  Mai-Lan N Huynh; Valerie A Fadok; Peter M Henson
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

5.  Intact epithelial barrier function is critical for the resolution of alveolar edema in humans.

Authors:  M A Matthay; J P Wiener-Kronish
Journal:  Am Rev Respir Dis       Date:  1990-12

6.  Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome.

Authors:  K P Steinberg; J A Milberg; T R Martin; R J Maunder; B A Cockrill; L D Hudson
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

7.  Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome.

Authors:  G U Meduri; G Kohler; S Headley; E Tolley; F Stentz; A Postlethwaite
Journal:  Chest       Date:  1995-11       Impact factor: 9.410

8.  Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.

Authors:  Xinqi Peng; Paul M Hassoun; Saad Sammani; Bryan J McVerry; Melissa J Burne; Hamid Rabb; David Pearse; Rubin M Tuder; Joe G N Garcia
Journal:  Am J Respir Crit Care Med       Date:  2004-03-12       Impact factor: 21.405

9.  Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide.

Authors:  Iris Caramalho; Thiago Lopes-Carvalho; Dominique Ostler; Santiago Zelenay; Matthias Haury; Jocelyne Demengeot
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  8 in total

Review 1.  Update on acute lung injury and critical care medicine 2009.

Authors:  Michael A Matthay; Steven Idell
Journal:  Am J Respir Crit Care Med       Date:  2010-05-15       Impact factor: 21.405

2.  Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.

Authors:  Joshua M Diamond; Tatiana Akimova; Altaf Kazi; Rupal J Shah; Edward Cantu; Rui Feng; Matthew H Levine; Steven M Kawut; Nuala J Meyer; James C Lee; Wayne W Hancock; Richard Aplenc; Lorraine B Ware; Scott M Palmer; Sangeeta Bhorade; Vibha N Lama; Ann Weinacker; Jonathan Orens; Keith Wille; Maria Crespo; David J Lederer; Selim Arcasoy; Ejigayehu Demissie; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

3.  In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.

Authors:  Oscar E Simonson; Dimitrios Mougiakakos; Nina Heldring; Giulio Bassi; Henrik J Johansson; Magnus Dalén; Regina Jitschin; Sergey Rodin; Matthias Corbascio; Samir El Andaloussi; Oscar P B Wiklander; Joel Z Nordin; Johan Skog; Charlotte Romain; Tina Koestler; Laila Hellgren-Johansson; Petter Schiller; Per-Olof Joachimsson; Hans Hägglund; Mattias Mattsson; Janne Lehtiö; Omid R Faridani; Rickard Sandberg; Olle Korsgren; Mauro Krampera; Daniel J Weiss; Karl-Henrik Grinnemo; Katarina Le Blanc
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

4.  Activation of regulatory T cells during inflammatory response is not an exclusive property of stem cells.

Authors:  Jan-Hendrik Gosemann; Joachim F Kuebler; Michela Pozzobon; Claudia Neunaber; Julia H K Hensel; Marco Ghionzoli; Paolo de Coppi; Benno M Ure; Gesine Holze
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

5.  Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner.

Authors:  Emily K Moser; Matthew M Hufford; Thomas J Braciale
Journal:  PLoS Pathog       Date:  2014-08-21       Impact factor: 6.823

6.  Initiation of LPS-induced pulmonary dysfunction and its recovery occur independent of T cells.

Authors:  Eva Verjans; Stephanie Kanzler; Kim Ohl; Annette D Rieg; Nadine Ruske; Angela Schippers; Norbert Wagner; Klaus Tenbrock; Stefan Uhlig; Christian Martin
Journal:  BMC Pulm Med       Date:  2018-11-22       Impact factor: 3.317

7.  Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.

Authors:  Steven M Lipkin; Eduardo Vilar; Laura Reyes-Uribe; Wenhui Wu; Ozkan Gelincik; Prashant V Bommi; Alejandro Francisco-Cruz; Luisa M Solis; Patrick M Lynch; Ramona Lim; Elena M Stoffel; Priyanka Kanth; N Jewel Samadder; Maureen E Mork; Melissa W Taggart; Ginger L Milne; Lawrence J Marnett; Lana Vornik; Diane D Liu; Maria Revuelta; Kyle Chang; Y Nancy You; Levy Kopelovich; Ignacio I Wistuba; J Jack Lee; Shizuko Sei; Robert H Shoemaker; Eva Szabo; Ellen Richmond; Asad Umar; Marjorie Perloff; Powel H Brown
Journal:  Gut       Date:  2020-07-08       Impact factor: 23.059

8.  ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19.

Authors:  Kieran McCafferty; Zoe Hollowood; Michelle Allen; Donna Lockhart; Jamie Chorlton; John Martin
Journal:  BMJ Open       Date:  2021-12-01       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.